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Case report
  A 45-year-old male presented for elective surgery to 
repair an enlarging ventral hernia. Past medical history was  
significant for diabetes mellitus and exploratory laparotomy 
for a bleeding peptic ulcer, 18 years prior. In addition to a 
well-healed midline abdominal incision, the physical ex-
amination found a 4 x 3-cm midline ventral hernia. Nor-
mal bowel sounds were elicited in a soft, nontender abdo-
men. Laboratory tests were significant only for an elevated 
glucose, 192 mg/dl, compatible with the given history of  
diabetes. 
During the initial operative procedure, an unexpected 
mass was felt below the transverse colon (Fig. 1). Unaware 
of  its content and potential complications, an immediate 
intraoperative consultation to surgical oncology was ob-
tained, as well as an intraoperative sonogram. The recom-
mendation was to not perform intraoperative tissue sam-
pling at this time. Instead, the abdomen was closed and the 
patient was immediately escorted to the radiology depart-
ment for a CT scan of  the abdomen and pelvis to further 
assess the mass. CT images revealed huge multiseptated 
masses (Fig. 2) with predominantly macroscopic “fat” at-
tenuation, occupying almost the entire abdomen and upper 
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Adrenal myelolipomas are fat-containing tumors that are rare, usually small and unilateral, as well as as-
ymptomatic. They can, however, occur bilaterally and enlarge significantly, resulting in clinical symp-
toms. A middle-aged male presented with an enlarging ventral hernia that was attributed to giant bilat-
eral adrenal myelolipomas. With a combined measurement of  at least 20 x 15 cm, the size of  the masses 
is one of  the largest reported for this particular entity, to our knowledge.
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Fig. 1. Giant adrenal myelolipoma in a 45-year-old male 
presenting for ventral hernia repair. Intraoperative image 
shows a large unexpected abdominal mass (white arrow) 
representing a segment of an adrenal myelolipoma that 
accounted for an enlarging ventral hernia.
pelvis. MRI showed complementary findings 
(images not shown). Based on imaging, the 
major contenders in the differential diagnosis, 
especially due to the large size of  the mass(es), 
included predominantly fat-containing pri-
mary adrenal and/or retroperitoneal masses 
such as bilateral myelolipomas, lipomas, lipo-
sarcoma(s), bilateral exophytic angiomyolipo-
mas, and teratoma(s), with metastatic disease 
(containing fat), rounding out the list. Strik-
ingly, both kidneys were inferiorly displaced 
(Fig. 2) into the pelvis, while maintaining cor-
tical continuity; this was an important finding 
that narrowed the differential possibilities to 
bilateral fat-containing suprarenal masses. 
During a followup surgical procedure, which 
also included a true cut biopsy, only predomi-
nantly midline and left abdominal masses 
were resected due to excessive hemorrhage. 
Tissue samples were submitted to pathology 
for histological review. 
    At a later date, the patient succumbed to 
cardiovascular complications, and an autopsy 
was ultimately performed. Microscopic ex-
amination of  representative sections from both 
suprarenal masses, as well as from the prior 
biopsy, revealed adipose tissue containing he-
matopoietic cells showing tri-lineage hemato-
poiesis (Fig. 3). These results, along with a tu-
mor size greater than 10 cm, confirmed the     
diagnosis of  giant bilateral myelolipomas. 
Discussion
 Incidence and clinical presentation
Due to their benign indolent nature, most ad-
renal myelolipomas are discovered incidentally 
(especially given the increased use of  cross-sectional imag-
ing modalities), or at autopsy, with an incidence of  0.03% 
to 0.2% (1). With the widespread use of  noninvasive imag-
ing, including ultrasound, computed tomography (CT), and 
magnetic resonance imaging (MRI), incidental detection of 
myelolipomas is becoming more common, and they consti-
tute up to 10-15% of  incidental adrenal masses (2). 
Adrenal myelolipomas are rare, usually small (less than 4 
cm), and asymptomatic (70%) (1) tumors. They were first 
described by Gierke in 1905 (2, 3-5), and given the name 
“myelolipoma” by Oberling in 1929 (4). Myelolipomas, 
however, can occur bilaterally and/or enlarge significantly. 
Tumors weighing several kilograms have been reported (4, 
6) and can result in clinical symptoms (from the size alone 
and/or mass effect) such as abdominal or flank pain, nau-
sea, vomiting, or (as in our patient) a ventral hernia. Acute 
intratumoral or retroperitoneal hemorrhage (4) can occur 
spontaneously as these tumors enlarge. Though they are 
known as hormonally inactive tumors, symptoms from 
hormonal activity from a variety of  associated endocrine 
disorders have been reported (for example, Addison’s dis-
ease, Cushing’s syndrome, Conn’s syndrome, obesity, viril-
Bilateral giant adrenal myelolipomas presenting as an enlarging ventral hernia
RCR Radiology Case Reports | radiology.casereports.net 2 2015 | Volume 10 | Issue 2
Fig. 2. Fat-containing retroperitoneal 
masses in a 45-year-old male presenting for ventral hernia 
repair.(A) Transverse, contrast-enhanced CT image through 
the abdomen shows multiple large well-encapsulated retro- 
(long white arrow) and intraperitoneal (long yellow arrow) 
masses, predominately composed of fat-attenuated tissue 
interspersed with enhancing septa. Masses occupy almost 
the entire central abdominal cavity, with anterolateral dis-
placement and compression of bowel loops (arrowhead). 
The size and complexity of the fat-containing lesions 
prompted the initial diagnosis of liposarcoma with a differen-
tial diagnosis of myelolipoma. (B) Sagittaland (C) coronal 
contrast-enhanced CT images illustrate inferior displace-
ment of the kidneys (yellow stars; sagittal view of right kid-
ney not shown) by large multiseptated fat-attenuated le-
sions. The bilateral renal cortex is not violated (yellow ar-
rowheads), suggesting a suprarenal component/origin such 
as bilateral myelolipomas. (D) Coronal view from same CT 
scan illustrates the largest component of the masses, 21 x 
12 cm, extending from the thoracoabdominal junction to the 
mid pelvis. (Incidentally, the presenting ventral hernia was 
reduced intraoperatively, which occurred prior to imaging 
with CT; see history in case report.)
ism, and pseudo-hermaphroditism [3]). The associations 
with diabetes mellitus, hypertension, obesity, atherosclerosis, 
and malignancy have also been described (2, 5), and mye-
lolipomas can also occur in the setting of  burns (7).
Location and histology
Myelolipomas predominantly arise from the adrenal cor-
tex, with possible origin from the zona fasciculata layer (8), 
the middle of  the three layers composing the adrenal cortex 
(outermost layer, Zona glomerulosa; innermost layer, Zona 
reticularis). These tumors, however, may exist in an extra-
adrenal location in approximately 15% of  the cases (5), 
including the presacral region, perirenal retroperitoneum, 
liver, stomach, mediastinum, and lung (3). They affect both 
males and females (ratio, 1.75:1), with a higher incidence in 
the fifth and sixth decades of  life (6). When unilateral, these 
tumors show a predilection to the right side (right:left ratio, 
3:2.1) (3). Again, the size is usually less than 4 cm, and they 
are considered “giant myelolipomas” when the diameter is 
greater than 10 cm (6). 
Several theories have been proposed to explain the 
pathogenesis of  this tumor, including the following: foci of  
extramedullary hematopoiesis, hyperplasia of  myeloid cells 
misplaced during embryogenesis, or the result of  a degen-
erative process in hyperplastic or adenomatous glands (9). 
However, Meaglia and Schmidt proposed the most widely 
accepted theory, based on the existence of  metaplasia of  
the reticuloendothelial cells of  blood capillaries, located in 
the adrenal gland, in response to stimuli such as infection, 
necrosis, and stress (3). 
Myelolipomas are composed of  a mixture of  mature 
adipose tissue and hematopoietic elements (10), including 
some with calcifications. This explains the sometimes het-
erogeneous appearance seen on imaging, though the classic 
presentations of  small myelolipomas illustrate distinct ra-
diographic findings on cross-sectional modalities. The im-
aging features that distinguish this tumor are based on (a) 
the suprarenal location and (b) the fat content, with CT 
being the most sensitive of  the modalities (2). 
Imaging
The typical appearance of  myelolipomas on CT imaging 
is of  a predominantly low-attenuated, well-encapsulated 
lesion with negative Hounsfield (HU) units corresponding 
to the “fat”-attenuated range (macroscopic fat with HU of  
-31 to -100 [11]). The larger masses more clearly show the 
interspersed, high-attenuated, myeloid components (as well 
as other tissue types included in the previously mentioned 
differential diagnosis). On MRI, the dominant content, fat, 
is hyperintense on T1-weighted images and loses signal on 
fat-suppressed, T1-weighted and -opposed phase se-
quences. Sonographically, an echogenic mass appears due 
to the fatty content, though varying degrees of  hypoecho-
genicity may be represented due to the myeloid compo-
nent. Thus, the imaging appearance of  myelolipomas (that 
is, the degree of  heterogeneity) depends on the relative 
proportion of  macroscopic fat and myeloid present in the 
tumors (11). 
In early reported cases of  adrenal myelolipoma imaged 
with FDG-PET, usually no significant metabolic uptake 
was shown (12, 13). However, more recently, Ludwig et al 
(12) reported mixed metabolic activity in a myelolipoma, 
suggesting that the lack of  activity corresponds to “necrotic 
and adipose” elements in the tumor, and that the presence 
of  activity (that is, if  the tumor is FDG-PET avid) corre-
sponds to the “adenomatous and hematopoietic” elements. 
When imaging results are equivocal, especially when the 
tumor is large and/or heterogeneous and interspersed with 
fat and denser nonfatty myeloid tissue on CT, then image-
guided, fine-needle aspiration may be warranted. Further 
rendering the diagnosis unclear is the presence of  calcifica-
tions, seen in about 27% (2, 14) of  myelolipomas, and tu-
mor enhancement, which has been reported (15). Extra-
adrenal myelolipomas may mimic extramedullary hemato-
poietic tumors, especially since bone spicules have been 
reported (14). 
Clinical management
The management of  adrenal myelolipomas should be 
determined on an individual basis. Incidentally discovered, 
small, asymptomatic tumors with unequivocal radiological 
findings can be monitored, with no need for immediate 
surgical intervention (9), though close monitoring is advised 
in the event of  unexpected growth and development of  
symptoms. Initial operative intervention is reserved for 
symptomatic patients (9), as was the case in this particular 
scenario, or for those patients with a large silent tumor that 
can produce life-threatening shock secondary to spontane-
ous hemorrhage (9). However, Meyer and Behrend advo-
cate surgery for tumor size greater than 10 cm because of  
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Fig 3. Light microscopy features of adrenal myelolipoma. 
Islands of hematopoietic tissue with conspicuous megakar-
yocytes (black star) within residual adrenal cortical cells 
(black diamond), mature fat cells (arrowhead), and intersti-
tial hemorrhage (black arrow) (hematoxylin-eosin stain; 
original magnification 200x).
the small but distinct risk of  developing abdominal pain or 
life-threatening hemorrhage that may be associated with 
large myelolipomas (5). Again, CT-guided aspiration or 
biopsy can be done initially to confirm the diagnosis when-
ever it is in doubt (9), though this procedure is not without 
risk of  rupture and bleeding (16). In addition to the very 
rare complication of  a spontaneous bleed (especially in the 
larger tumors), there are several reports in the literature of  
spontaneous rupture of  adrenal myelolipomas (17). In such 
cases, as reported by V. G. Patel (5), surveillance can be 
accomplished with serial CT or ultrasound examinations. If 
surgical intervention is required, preservation of  adrenal 
tissue is vital so as not to commit patients to a lifetime of  
steroid replacement (17). Though laparoscopic adrenalec-
tomy is gaining widespread acceptance as the gold-standard 
technique for benign adrenal masses smaller than 5 to 7 
cm, the literature cites successful outcomes with the laparo-
scopic approach in larger lesions, provided that a good pre-
operative diagnosis is done (with imaging and endocrine 
evaluation) (18, 19). 
Conclusion
While bilateral myelolipomas are usually small, unilateral 
and asymptomatic, our reported case of  giant bilateral 
myelolipomas is a unique appearance of  this tumor, with an 
uncommon presentation as an enlarging ventral hernia. 
Incidentally, to the authors’ knowledge, cross-sectional im-
aging is not required in the routine surgical evaluation of  
seemingly uncomplicated ventral hernias; however, physi-
cians should be aware that an underlying unexpected mass 
may be the root cause, as illustrated in this presentation. In 
the setting of  a small, unilateral, asymptomatic retroperito-
neal tumor, CT imaging can quickly establish a supra-renal 
origin of  the mass and identify “fat” content within the 
lesion, to render a diagnosis of  myelolipoma. On the other 
hand, in the setting of  larger (sometimes massive) “fat”-
containing abdominal tumors that lack classical CT find-
ings, histological confirmation (via image-guided percuta-
neous biopsy) may be warranted to confirm the diagnosis of 
a giant myelolipoma (or other fat-containing adrenal or 
other retroperitoneal masses), as was necessary in this par-
ticular scenario.
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